Michael R. Pavia
Director/Board Member at Azevan Pharmaceuticals, Inc.
Profile
Dr. Michael R.
Pavia is Entrepreneur-in-Residence at Oxford Bioscience Partners, Prior to joining Oxford Bioscience Partners in 2002, Dr. Pavia was Chief Technology Officer at Millennium Pharmaceuticals, where his major focus was to improve the productivity of the drug discovery and development process through the appropriate use of new technologies.
He has years of experience in pharmaceutical research and discovery.
He was formerly Vice President of Cambridge Research at Sphinx Pharmaceuticals, a division of Eli Lilly & Co., focusing on the development of combinatorial chemistry technologies.
Prior to Sphinx, he held senior scientific positions in the Department of Chemistry at the Parke-Davis Pharmaceutical Research Division of Warner-Lambert.
Dr. Pavia holds a BS in Chemistry from Lehigh University and a PhD in Organic Chemistry from the University of Pennsylvania.
Michael R. Pavia active positions
| Companies | Position | Start |
|---|---|---|
Azevan Pharmaceuticals, Inc.
 Azevan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azevan Pharmaceuticals, Inc. develops novel therapeutics to treat disorders of stress, mood, and behavior. Its first clinical compounds selectively block the effects of arginine vasopressin, a peptide neurohormone involved in the pathophysiology of neuropsychiatric symptoms in neurodegenerative diseases and a broad range of stress-related affective disorders, including Post-traumatic Stress Disorder (PTSD), Intermittent Explosive Disorder, and major depression. The company was founded by Craig F. Ferris and Neal Gordon Simon in 1999 and is headquartered in Bethlehem. | Director/Board Member | - |
Former positions of Michael R. Pavia
| Companies | Position | End |
|---|---|---|
| Sphinx Pharmaceuticals Corp | Corporate Officer/Principal | - |
Segterra, Inc.
 Segterra, Inc. Medical/Nursing ServicesHealth Services Segterra, Inc. engages in the development and marketing of a health and fitness analytics platform. It offers InsideTracker, which tracks and analyzes key biochemical and physiological markers and applies algorithms and scientific databases to determine personalized optimal zones for each marker. The company was founded by Richard Arnstein, Gil Blander, Christina Reich and David Lester in 2009 and is headquartered in Cambrdige, MA. | Director/Board Member | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | - |
| GLORI ENERGY INC. | Chief Tech/Sci/R&D Officer | - |
The North Carolina Biotechnology Center
 The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC. | Director/Board Member | - |
Training of Michael R. Pavia
| Lehigh University | Undergraduate Degree |
| University of Pennsylvania | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| GLORI ENERGY INC. | Industrial Services |
| Private companies | 8 |
|---|---|
Selventa, Inc.
 Selventa, Inc. Miscellaneous Commercial ServicesCommercial Services Selventa, Inc. develops new approaches for the understanding and treatment of diseases. It focuses on elucidating the complexity of biology for the development of safe and effective therapeutics and molecular diagnostics. The company was founded in 2002 by Keith O. Elliston and Noubar B. Afeyan and is headquartered in Cambridge, MA. | Commercial Services |
Oxford Bioscience Partners
 Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston. | Finance |
Luca Technologies, Inc.
 Luca Technologies, Inc. Integrated OilEnergy Minerals Luca Technologies, Inc. operates as a clean energy company. Its proprietary technology stimulates native microorganisms that reside in subsurface hydrocarbon deposits, such as coal, oil and organic-rich shales to accelerate the bioconversion of such resources into methane, the principal component of natural gas, which the company produces and sells using existing infrastructure. The company was founded by Eric Szaloczi, R. Verlin Dannar, Jeffrey L. Weber, Robert S. Pfeiffer, Michael P. Batzer, Christie L. Haas, Roland P. DeBruyn, and Allan F. Wise in April 2003 and is headquartered in Golden, CO. | Energy Minerals |
Azevan Pharmaceuticals, Inc.
Azevan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azevan Pharmaceuticals, Inc. develops novel therapeutics to treat disorders of stress, mood, and behavior. Its first clinical compounds selectively block the effects of arginine vasopressin, a peptide neurohormone involved in the pathophysiology of neuropsychiatric symptoms in neurodegenerative diseases and a broad range of stress-related affective disorders, including Post-traumatic Stress Disorder (PTSD), Intermittent Explosive Disorder, and major depression. The company was founded by Craig F. Ferris and Neal Gordon Simon in 1999 and is headquartered in Bethlehem. | Health Technology |
The North Carolina Biotechnology Center
The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC. | Technology Services |
Segterra, Inc.
Segterra, Inc. Medical/Nursing ServicesHealth Services Segterra, Inc. engages in the development and marketing of a health and fitness analytics platform. It offers InsideTracker, which tracks and analyzes key biochemical and physiological markers and applies algorithms and scientific databases to determine personalized optimal zones for each marker. The company was founded by Richard Arnstein, Gil Blander, Christina Reich and David Lester in 2009 and is headquartered in Cambrdige, MA. | Health Services |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
| Sphinx Pharmaceuticals Corp | Health Technology |
- Stock Market
- Insiders
- Michael R. Pavia
